Avian Influenza A/H7N9 Vaccine Mixed with MF59 Adjuvant at the Point-of-Use. A Randomized Clinical Trial of a Pandemic Threat Response. In ID Week 2014. presented at the 08/10/2014, Philadelphia, PA. Retrieved from http://www.idweek.org/post-meeting-tools/. (2014).
VRC 702: A Multicenter Phase 1 Study of Seasonal Influenza DNA Vaccine Prime Followed by the Trivalent Inactivated Vaccine (TIV) Compared to TIV-TIV in Children and Adolescents Ages 6-17 Years. In 2014 Annual Conference on Vaccine Research. presented at the 28/04/2014, Bethesda, MD. Retrieved from http://www.cvent.com/events/17th-annual-conference-on-vaccine-research/event-summary-742976fb42dc43849867074b2754bed7.aspx?refid=nfid. (2014).
Correlate of Immune Protection Against HSV-1 Genital Disease in Vaccinated Women. J Infect Dis, 209, 828-836. presented at the 03/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24285844. (2014).
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infec Dis, 181, 11133-7. presented at the 2000.. (2000).
Diminution of the Anti-PRP response to a combined DtaP/Hib vaccine by concurrent inactivated poliovirus vaccination. Ped J Infec Dis, 19, 417-23. presented at the 2000.. (2000).
DNA Priming for Seasonal Influenza Vaccine: a Phase 1b Double-Blind Randomized Clinical Trial. PLoS One, 10, e0125914. presented at the 05/2015. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25950433. (2015).
Effects of Adjuvants on the Safety and Immunogenicity of an Avian Influenza H5N1 Vaccine in Adults. J Infec Dis, 197, 667-675. presented at the 03/2008. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18260764. (2008).
The efficacy of live attenuated, cold adapted, trivalent, intranasal, influenza virus vaccine in children. N Engl J Med, 338, 1405-12. presented at the 1998.. (1998).
Efficacy of Vaccination with Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenza Virus Vaccine Against a Variant (A/Sidney) not Contained in the Vaccine. J Pediatric, 136, 168-175. presented at the 02/2000. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/10657821. (2000).
Efficacy Results of A Trial of A Herpes Simplex Vaccine. N Engl J Med, 366, 34-43. presented at the 05/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22216840. (2012).
Epidemiology, Clinical Presentation, and Antibody Response to Primary Infection With Herpes Simplex Virus Type 1 and Type 2 in Young Women. Clin Infect Dis, 56, 344-351. presented at the 02/2013. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23087395. (2013).
HSV-1 and HSV-2 Seroprevalence in the United States Among Asymptomatic Women Unaware of any Herpes Simplex Virus Infection (Herpevac Trial for Women). Southern Medical Journal, 107, 79-84. presented at the 02/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24926671. (2014).
Immunogenicity and Safety of Four Different Dosing Regimens of Anthrax Vaccine Adsorbed for Post-Exposure Prophylaxis for Anthrax in Adults. Vaccine, 32, 6284-6293. presented at the 09/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25239484. (2014).
Norovirus Vaccine Against Experimental Human Norwalk Virus Illness. N Engl J Med, 365, 2178-2187. presented at the 12/2011. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22150036. (2011).
A Phase I Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimeric Vaccines. J Infec Dis, 193, 1350-1360. presented at the 05/2006. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16619181. (2006).
Phase II Trial in Adults of Concurrent or Sequential 2009 Pandemic H1N1 and 2009-2010 Seasonal Trivalent Influenza Vaccinations. Vaccine, 33, 163-173. presented at the 01/2015. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25444805. (2015).
Safety and Immune Responses in Children After Concurrent or Sequential 2009 H1N1 and 2009-2010 Seasonal Trivalent Influenza Vaccinations. J Infect Dis, 206, 828-837. presented at the 09/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed?term=22802432. (2012).
Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine. J Amer Med Assn, 292, 1205-1212. presented at the 2004.. (2004).